Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Nov-15 8:07 PM View:  | Dionne Craig A CEO, CFO, President Director 10% Owner | Inspyr Therapeutics, Inc. (NSPX) | 02-Nov-15 | Conversion | 262,500 | $0.40 | $105,000.00 | 18% 1.45M to 1.71M | (93%) |
| 09-Oct-15 8:15 PM View: | Dionne Craig A CEO, CFO, President Director 10% Owner | Inspyr Therapeutics, Inc. (NSPX) | 06-Oct-15 | Disposition (other) | 1,000,000 | -- | -- | (26%) 3.88M to 2.88M | |
| 09-Oct-15 8:15 PM View: | Dionne Craig A CEO, CFO, President Director 10% Owner | Inspyr Therapeutics, Inc. (NSPX) | 06-Oct-15 | Acquisition (other) | 415,738 | -- | -- | 17% 2.46M to 2.88M | |
| 09-Oct-15 8:15 PM View: | Dionne Craig A CEO, CFO, President Director 10% Owner | Inspyr Therapeutics, Inc. (NSPX) | 06-Oct-15 | Disposition (other) | 415,738 | -- | -- | (14%) 2.88M to 2.46M | |
| 09-Oct-15 8:15 PM View: | Dionne Craig A CEO, CFO, President Director 10% Owner | Inspyr Therapeutics, Inc. (NSPX) | 06-Oct-15 | Acquisition (other) | 1,000,000 | -- | -- | 35% 2.88M to 3.88M |
